HB 2402 Washington House · 2025-2026 Regular Session

Concerning phthalates in medical equipment used for intravenous purposes.

HB 2402 bans the use of DEHP (a phthalate chemical) in intravenous (IV) medical equipment in Washington state. Starting January 1, 2030, it prohibits manufacturing, selling, or distributing IV bags containing intentionally or unintentionally added DEHP above 0.1% weight per weight, with IV tubing restrictions beginning January 1, 2035. The law also forbids replacing DEHP with other phthalates and exempts certain blood collection products. It directly affects medical device manufacturers, distributors, and healthcare facilities in Washington, requiring them to transition to DEHP-free alternatives by the specified deadlines. The bill aims to reduce exposure to DEHP, linked to health risks including endocrine disruption and potential cancer concerns, through concrete phase-out timelines.

Issues: ✓ Environment ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2026

Committee Review

Floor Vote

Governor

Introduced Jan 13, 2026 Last action Feb 4, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Bill → Substitute Bill · 4 edits

MODERATE

The bill was amended to reflect its progression through the legislative process, changing the title from 'House Bill' to 'Substitute House Bill' and updating the sponsor attribution to include the House Health Care & Wellness committee. The substantive policy content regarding phthalate restrictions remains unchanged.

Scope change

The bill's scope and applicability remain unchanged; only the procedural metadata regarding committee referral and sponsorship was updated.

TECHNICAL

The bill title was updated from 'House Bill' to 'Substitute House Bill' to indicate it has been amended by a committee or another chamber.

The sponsor attribution was updated to show the bill is now sponsored by the House Health Care & Wellness committee, rather than just the original individual representatives.

The reading date was updated from January 13, 2026, to February 4, 2026, reflecting the new date the bill was read in the House.

The bill number was changed from H-2542.3 to H-3353.1, likely reflecting a new numbering sequence for the substitute version.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 4, 2026

Committee

Referred to Rules 2 Review.

lower

Feb 4, 2026

Lower · Passed

Minority; without recommendation.

lower

Feb 4, 2026

Lower · Passed

Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

lower

Jan 23, 2026

Lower · Passed

Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.

lower

Jan 15, 2026

Committee

Referred to Health Care & Wellness.

lower

Jan 15, 2026

Lower · Passed

Committee relieved of further consideration.

lower

1 primary · 3 co-sponsors